SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-033436
Filing Date
2010-06-16
Accepted
2010-06-16 15:38:09
Documents
1
Period of Report
2010-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd279281.html 4  
1 FORM 4 rrd279281.xml 4 3154
  Complete submission text file 0001181431-10-033436.txt   5340
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Reporting) CIK: 0001003124 (see all company filings)

State of Incorp.: NC | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 10900583
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-380-2000
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations